Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-05

Clinical Trial Update: Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections [NA]

View source ↗

Summary

The study evaluated the role of the nuclear pore component RANBP2 in inflammatory responses to viral infections, focusing on acute necrotizing encephalopathy in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Rare Genetic Disease, Acute Necrotizing Encephalopathy | NA | Status: COMPLETED